Skip to content

13F-HR filed by JW Asset Management, LLC

JW Asset Management, LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 39 holding rows worth $150,276,000.

Accession
0001420506-17-000212
Filed
2017-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 39 entries on the cover page, a total value of $150,276,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $150,276,000 with VALUE read as thousands by filing date, 13F file number 028-16404. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EAGLE PHARMACEUTICALS INC269796108COM525,755$41,714,000thousands by filing date
Goldman Sachs Group,Inc.38141G104COM73,064$17,496,000thousands by filing date
Amazon.com, Inc023135106COM16,613$12,458,000thousands by filing date
ARALEZ PHARMACEUTICALS INC03852X100COM2,680,140$11,820,000thousands by filing date
Alphabet Inc. Reg. Shares A02079K305COM10,500$8,321,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS507,075$8,205,000thousands by filing date
NVIDIA Corp67066G104COM55,000$5,871,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON444,439$4,618,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM73,649$4,103,000thousands by filing date
Microsoft Corp594918104COM60,000$3,729,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW36,086$3,667,000thousands by filing date
WINGSTOP INC COM974155103Stock116,057$3,435,000thousands by filing date
UnitedHealth Group Inc91324P102COM20,000$3,201,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW324,280$2,731,000thousands by filing date
ANTARES PHARMA INC036642106COM1,092,830$2,547,000thousands by filing date
MARTIN MARIETTA MATLS INC COM573284106Stock10,000$2,216,000thousands by filing date
CAMBREX CORP132011107COM40,519$2,187,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM3,000$1,903,000thousands by filing date
JUNIPER PHARMACEUTICALS INC COM48203L107Stock328,133$1,838,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM29,722$1,802,000thousands by filing date
META PLATFORMS INC CL A30303M102COM10,000$1,151,000thousands by filing date
DEPOMED INC249908104COM57,924$1,044,000thousands by filing date
LULULEMON ATHLETICA INC550021109COM10,000$650,000thousands by filing date
DIGIRAD CORP253827109COM110,257$552,000thousands by filing date
Micron Technology,Inc.595112103COM25,000$548,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock178,654$519,000thousands by filing date
MYLAN NVN59465109SHS EURO10,000$382,000thousands by filing date
GROUPON INC399473107COMMON STOCK110,400$367,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK29,409$271,000thousands by filing date
PULSE BIOSCIENCES INC74587B101COMMON STOCK37,454$229,000thousands by filing date
WEIGHT WATCHERS INTL INC948626106COM20,000$229,000thousands by filing date
COMSCORE INC20564W105COM5,000$158,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM5,000$104,000thousands by filing date
TELIGENT INC NEW87960W104COM13,820$92,000thousands by filing date
CUMBERLAND PHARMACEUTICALS I230770109COM10,939$61,000thousands by filing date
CTI BIOPHARMA CORP COM NEW12648L106Stock50,254$21,000thousands by filing date
MEDICAL TRANSCRIPTION BLG CO58464J105COM22,903$17,000thousands by filing date
ONCOBIOLOGICS INC68235M105COM5,162$16,000thousands by filing date
SOLIGENIX INC834223307COM989$3,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-17-000212this filing2017-02-14acceptance time not in the bulk data set